FAST NEWS: Ascletis Covid, Monkeypox Virus Inhibitor Gets U.S. Patent
The latest: Ascletis Pharma Inc. (1672.HK) said on Monday the U.S. Patent and Trademark Office (USPTO) has granted it a patent for its oral viral polymerase inhibitor ASC10 and its…
RELATED ARTICLES
-
As Covid drug cash dwindles, Vigonvita targets new remedies
-
Everest gets boost from core product Nefecon’s inclusion in China’s national health plan
1952.HK
-
Everest Medicines eyes mRNA tumor vaccines as drug valuations rebound
1952.HK
- Cancer drug maker Genfleet joins Hong Kong IPO influx
-
Cancer drug maker Biostar shines on Hong Kong market debut
2563.HK
-
A blockbuster cancer drug? TYK’s claims go under the microscope
2410.HK
-
Dispute over Covid vaccines casts doubt on Clover Bio recovery
2197.HK
